I
Isu Abxis Co Ltd
KOSDAQ:086890
Isu Abxis Co Ltd
KOSDAQ:086890
Price:
6 450 KRW
Market Closed
Updated:
Jun 1, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
2.4
Current
4.9
Median
7.1
Industry
Lower
than median
Lower
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=2.4
Enterprise Value
/
128.6B
Revenue
54.3B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| KR |
I
|
Isu Abxis Co Ltd
KOSDAQ:086890
|
223.2B KRW | 2.4 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
284.7B USD | 6.1 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
164.1B USD | 7.3 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
117.6B USD | 10.6 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
108B USD | 7.6 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.3B AUD | 7 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
80.1B USD | 3.5 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
54.6B USD | 9.1 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.2 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
32.8B USD | 3.9 | |
| IE |
|
Horizon Therapeutics PLC
NASDAQ:HZNP
|
26.6B USD | 7.3 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
1.8
2-Years Forward
EV/S
1.5
3-Years Forward
EV/S
N/A
You don't have any saved screeners yet
